Indore-based WHO-GMP pharmaceutical formulations manufacturer known as one of central India's largest ORS sachet makers, also producing liquid orals, ointments/creams, capsules and tablets.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 0 | 0 | 0 | 0 | 17 | 17 | 17 | 17 |
| Reserves | 6 | 9 | 12 | 17 | 45 | 52 | 55 | 58 |
| Borrowings | 12 | 15 | 17 | 25 | 24 | 49 | 52 | 55 |
| Other Liabilities | 25 | 21 | 37 | 54 | 48 | 44 | 42 | 57 |
| Total Liabilities | 44 | 47 | 66 | 97 | 134 | 161 | 165 | 188 |
| AssetsFixed Assets | 6 | 9 | 10 | 11 | 11 | 40 | 42 | 41 |
| CWIP | 3 | 0 | 0 | 0 | 4 | 3 | 4 | 10 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 35 | 37 | 56 | 86 | 119 | 118 | 119 | 136 |
| Total Assets | 44 | 47 | 66 | 97 | 134 | 161 | 165 | 188 |
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 3 | -1 | 5 | -4 | -16 | -5 | 9 |
| Cash from Investing | -5 | -2 | -3 | -2 | -5 | -31 | -14 |
| Cash from Financing | 1 | 3 | -1 | 6 | 30 | 28 | 5 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — |
| Free Cash Flow | -1 | -2 | 2 | -6 | -21 | -37 | -5 |
| FCF Margin | — | — | — | — | — | — | — |
This looks cyclical, and we don't have enough quarters to establish a through-cycle earnings base. Valuing it off the current point in the cycle would be misleading.
ZENITHDRUG · CYCLICAL_UNMODELABLE
Guides on how to read this kind of business and the numbers that matter.